JMP Securities analyst Peter Martin previously valued Brookdale Senior Living on an NAV basis given the expectation of a sale at the conclusion of its strategic alternatives process. While he agrees with the board's decision not to sell the company at depressed levels, he now thinks the board needs to take ownership and that at least three of the four longest tenured board members should resign. He believes 2018 will be another "transitional year" and that weak 2018 guidance is coming and would be patient on an entry point. Martin lowered his price target on Brookdale to $9 from $16, but keeps an Outperform rating on the shares.